Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. announced that it received accreditation from Great Place To Work®, the global management consulting firm that provides best-in-class data about the employee experience and establishes benchmarks for working conditions around the world.
June 3, 2024
· 3 min read